Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Pacira BioSciences, Inc. (PCRX)
USD25.19
+0.18 (+0.72%)
US NASDAQ Healthcare Drug Manufacturers - Specialty & Generic
Address
5401 West Kennedy Boulevard 33609
Tampa, FL, US
Tampa, FL, US
CEO
Frank D. Lee
Website
pacira.com
IPO
2011-02-03
CIK 1396814 ISIN US6951271005
Description
Operating within the United States, Pacira BioSciences, Inc. is dedicated to providing healthcare professionals and their patients with non-opioid solutions for pain management and regenerative health. Its offerings include EXPAREL, an injectable liposomal bupivacaine suspension, and ZILRETTA, an extended-release injectable suspension of triamcinolone acetonide. Furthermore, the company offers the iovera system, a non-opioid, handheld cryoanalgesia device capable of delivering precisely controlled cold temperatures to targeted nerves. Pacira also develops its unique multivesicular liposome (MVL) drug delivery technology, which encapsulates therapeutic compounds while preserving their inherent molecular structure. Established in 2006, the firm was formerly known as Pacira Pharmaceuticals, Inc. until its name change to Pacira BioSciences, Inc. in April 2019. Its main corporate office is situated in Tampa, Florida.
News Sentiment (7d)
Based on only 1 article — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD25.19
+0.18 (+0.72%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
522.4K
Beta
0.27
Float Shares
37.74M
Free Float %
95.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.44% | -4.11% | -3.99% | +6.48% | -4.27% | -11.75% | -8.97% | -45.48% | -63.15% | -47.81% | +225.36% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (36 ratings, all time)
Hold
Price Targets & DCF
Current price
25.19
Low
27.00
+7.2%
Consensus
29.50
+17.1%
Median
29.50
+17.1%
High
32.00
+27.0%
DCF (Unlevered)
359.80
+1,328.3%
DCF (Levered)
395.39
+1,469.6%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
57% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 3 | 0 |
| Hold | 2 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 1 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
32.00
+27.0%
|
| Last Quarter | 1 |
32.00
+27.0%
|
| Last Year | 2 |
29.50
+17.1%
|
| All Time | 13 |
34.15
+35.6%
|
Quality scores
Altman Z-Score
1.84
Grey zone
Piotroski F-Score
8 / 9
Strong
MOAT Score
5 / 10
Developing
Composite Rating
B
Overall Score
3 / 5
Medium
DCF Score
5 / 5
High
ROE Score
3 / 5
Medium
ROA Score
3 / 5
Medium
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Drug Manufacturers - Specialty & Generic: +6.8%+3.6% Q1'26: +5.0% (vs Q1'25)
-
EPS growth Drug Manufacturers - Specialty & Generic: +16.5%+107.4% ★ Q1'26: -28.7% (vs Q1'25)
-
FCF margin FCF growth · Drug Manufacturers - Specialty & Generic: +32.3%+6.1% Q1'26: +12.9% (vs Q1'25)
-
EBIT margin Drug Manufacturers - Specialty & Generic: +13.0%+4.3% Q1'26: +4.6% (vs Q1'25)
-
ROIC Drug Manufacturers - Specialty & Generic: +6.5%+2.1% Q1'26: +2.3% (vs Q1'25)
-
Share dilution Drug Manufacturers - Specialty & Generic: +0.0%-2.6% ★ Q1'26: -12.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Drug Manufacturers - Specialty & Generic: -0.10×3.71× Q1'26: 3.48× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 4 Rev. Ana. 3 EPS Ana. |
Dec 2027 5 Rev. Ana. 4 EPS Ana. |
Dec 2028 5 Rev. Ana. 3 EPS Ana. |
Dec 2029 2 Rev. Ana. 2 EPS Ana. |
Dec 2030 2 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
85.55M
est: 72.76M (+17.6%)
|
197.67M
est: 190.10M (+4.0%)
|
249.00M
est: 247.95M (+0.4%)
|
276.37M
est: 276.52M (-0.1%)
|
286.63M
est: 286.60M (+0.0%)
|
337.28M
est: 334.30M (+0.9%)
|
421.03M
est: 419.90M (+0.3%)
|
429.65M
est: 430.43M (-0.2%)
|
541.53M
est: 536.73M (+0.9%)
|
666.82M
est: 666.80M (+0.0%)
|
674.98M
est: 681.75M (-1.0%)
|
700.97M
est: 698.86M (+0.3%)
|
726.41M
est: 729.87M (-0.5%)
|
766.31M
758.23M – 773.29M
+5.0% YoY
|
830.39M
823.26M – 844.34M
+8.4% YoY
|
954.16M
948.18M – 960.15M
+14.9% YoY
|
924.78M
915.04M – 933.21M
-3.1% YoY
|
935.18M
925.33M – 943.70M
+1.1% YoY
|
| EBITDA |
-50.73M
est: -45.77M (-10.8%)
|
5.09M
est: 1.32M (+286.0%)
|
21.39M
est: 18.38M (+16.4%)
|
-17.86M
est: 46.42M (-138.5%)
|
-10.59M
est: -19.69M (+46.2%)
|
33.06M
est: 37.01M (-10.7%)
|
30.75M
est: 25.65M (+19.9%)
|
63.51M
est: 56.50M (+12.4%)
|
113.95M
est: 105.18M (+8.3%)
|
140.38M
est: 165.92M (-15.4%)
|
154.59M
est: 116.65M (+32.5%)
|
29.12M
est: 120.22M (-75.8%)
|
122.50M
est: 125.56M (-2.4%)
|
131.83M
130.44M – 133.03M
+5.0% YoY
|
142.85M
141.62M – 145.25M
+8.4% YoY
|
164.14M
163.11M – 165.17M
+14.9% YoY
|
159.09M
157.41M – 160.54M
-3.1% YoY
|
160.88M
159.18M – 162.34M
+1.1% YoY
|
| EBIT |
-56.48M
est: -46.93M (-20.4%)
|
-5.89M
est: -7.55M (+22.0%)
|
9.46M
est: 7.21M (+31.2%)
|
-31.40M
est: 20.94M (-249.9%)
|
-25.81M
est: -44.87M (+42.5%)
|
19.89M
est: 17.41M (+14.2%)
|
11.17M
est: 8.31M (+34.5%)
|
43.60M
est: 43.30M (+0.7%)
|
85.40M
est: 82.64M (+3.3%)
|
48.88M
est: 96.88M (-49.5%)
|
79.01M
est: 43.07M (+83.4%)
|
-49.67M
est: 44.80M (-210.9%)
|
31.48M
est: 46.79M (-32.7%)
|
49.13M
48.61M – 49.57M
+5.0% YoY
|
53.23M
52.78M – 54.13M
+8.4% YoY
|
61.17M
60.79M – 61.55M
+14.9% YoY
|
59.29M
58.66M – 59.83M
-3.1% YoY
|
59.95M
59.32M – 60.50M
+1.1% YoY
|
| Net Income |
-63.91M
est: -56.36M (-13.4%)
|
-13.72M
est: -15.38M (+10.8%)
|
1.86M
est: -49.8K (+3,825.7%)
|
-37.95M
est: 25.04M (-251.5%)
|
-42.61M
est: -83.34M (+48.9%)
|
-471.0K
est: -2.31M (+79.6%)
|
-11.02M
est: -8.14M (-35.3%)
|
145.52M
est: 135.29M (+7.6%)
|
41.98M
est: 38.43M (+9.2%)
|
15.91M
est: 46.47M (-65.8%)
|
41.96M
est: 68.68M (-38.9%)
|
-99.56M
est: 145.88M (-168.2%)
|
7.03M
est: 133.55M (-94.7%)
|
127.61M
117.61M – 137.60M
-4.4% YoY
|
152.60M
121.98M – 183.22M
+19.6% YoY
|
218.25M
215.46M – 221.04M
+43.0% YoY
|
220.26M
217.24M – 222.86M
+0.9% YoY
|
236.47M
233.23M – 239.27M
+7.4% YoY
|
| SGA |
62.51M
est: 52.12M (+19.9%)
|
106.66M
est: 94.74M (+12.6%)
|
139.04M
est: 136.35M (+2.0%)
|
152.61M
est: 111.66M (+36.7%)
|
161.49M
est: 115.73M (+39.5%)
|
177.27M
est: 208.81M (-15.1%)
|
200.78M
est: 166.20M (+20.8%)
|
193.52M
est: 164.07M (+17.9%)
|
199.35M
est: 188.07M (+6.0%)
|
254.52M
est: 264.62M (-3.8%)
|
269.44M
est: 283.09M (-4.8%)
|
294.10M
est: 290.19M (+1.3%)
|
368.76M
est: 303.07M (+21.7%)
|
318.20M
314.85M – 321.10M
+5.0% YoY
|
344.81M
341.85M – 350.60M
+8.4% YoY
|
396.21M
393.72M – 398.69M
+14.9% YoY
|
384.00M
379.96M – 387.50M
-3.1% YoY
|
388.32M
384.23M – 391.86M
+1.1% YoY
|
| EPS |
-1.93
est: -1.29 (-49.6%)
|
-0.39
est: -0.33 (-20.0%)
|
0.05
est: 0.92 (-94.6%)
|
-1.02
est: 0.54 (-288.4%)
|
-1.07
est: -0.09 (-1,116.9%)
|
-0.01
est: 0.85 (-101.4%)
|
-0.27
est: 1.55 (-117.4%)
|
3.41
est: 2.14 (+59.1%)
|
0.95
est: 2.91 (-67.4%)
|
0.35
est: 2.63 (-86.7%)
|
0.91
est: 1.52 (-40.1%)
|
-2.15
est: 3.15 (-168.3%)
|
0.16
est: 2.95 (-94.6%)
|
2.85
2.61 – 3.05
-3.6% YoY
|
3.57
2.71 – 4.07
+25.5% YoY
|
4.85
4.78 – 4.91
+35.7% YoY
|
4.89
4.82 – 4.95
+0.8% YoY
|
5.25
5.18 – 5.31
+7.4% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-05-01 | Needham | Buy | Buy | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | B | 3/5 | 5/5 | 3/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-11 | B | 3/5 | 5/5 | 3/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-08 | B | 3/5 | 5/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-07 | B | 3/5 | 5/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-06 | B | 3/5 | 5/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-05 | B | 3/5 | 5/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-04 | B | 3/5 | 5/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-01 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-30 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-29 | B | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | B | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | B | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | B | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | B | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | B | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | B | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | B | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | B | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | B | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
144.33M
OE per share TTM
3.33
Owner's Yield
15.62%
Maintenance CapEx ratio
11.56%
Maint CapEx / Avg PPE
36.2%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
30
Total invested
33.99M
Insider transactions (90d)
4
Beneficial owners (>5%)
24
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | (1) BlackRock, Inc. | 6.82M | 15.30% | 6.74M | — | 6.82M | — | HC | Delaware | 2022-01-27 | ↗ |
| 2 | The Vanguard Group - 23-1945930 | 4.67M | 10.47% | — | 84.1K | 4.54M | 125.4K | IA | Pennsylvania For | 2022-02-10 | ↗ |
| 3 | FMR LLC | 3.84M | 10.54% | 336.00 | — | 3.84M | — | HC | Delaware | 2015-08-10 | ↗ |
| 4 | 10. | 3.75M | 8.41% | — | — | — | — | HC | Sydney, New South Wales Australia | 2022-02-14 | ↗ |
| 5 | Macquarie Bank Limited | 2.75M | 6.34% | — | — | — | — | CO | — | 2021-02-12 | ↗ |
| 6 | Macquarie Group Limited | 2.75M | 6.34% | — | — | — | — | HC | — | 2021-02-12 | ↗ |
| 7 | Macquarie Investment Management Business Trust | 2.75M | 6.34% | 2.75M | — | 2.75M | — | IA | — | 2021-02-12 | ↗ |
| 8 | Macquarie Investment Management Holdings Inc | 2.75M | 6.34% | 2.75M | — | 2.75M | — | HC | — | 2021-02-12 | ↗ |
| 9 | Delaware Smid Cap Growth Fund, a series of Delaware Group Equity Funds IV | 2.61M | 6.01% | 2.61M | — | 2.61M | — | IC | — | 2021-02-12 | ↗ |
| 10 | Baillie Gifford & Co (Scottish partnership) | 2.17M | 11.00% | — | — | — | — | IA | SCOTLAND UK | 2022-03-02 | ↗ |
| 11 | Steven A. Cohen | 2.04M | 5.10% | — | 2.04M | — | — | IN | Delaware | 2017-08-22 | ↗ |
| 12 | Point72 Asset Management, L.P. | 2.04M | 5.00% | — | 2.04M | — | — | PN | Delaware | 2017-08-22 | ↗ |
| 13 | Point72 Capital Advisors, Inc. | 2.04M | 5.00% | — | 2.04M | — | — | CO | Delaware | 2017-08-22 | ↗ |
| 14 | 2 | 1.88M | 5.10% | — | 1.88M | — | 1.88M | HC, OO | United States | 2015-08-10 | ↗ |
| 15 | 13-3127734 | 1.85M | 4.15% | 1.85M | — | 1.85M | — | HC | Delaware | 2022-02-10 | ↗ |
| 16 | 26-0385758 | 1.85M | 4.15% | 1.85M | — | 1.85M | — | IA | Delaware | 2022-02-10 | ↗ |
| 17 | 52-0556948 | 1.82M | 4.40% | 471.4K | — | 1.82M | — | IA | Maryland | 2018-02-14 | ↗ |
| 18 | Gilder, Gagnon, Howe & Co. LLC | 1.23M | 3.29% | 12.3K | — | 12.3K | — | BD | New York | 2017-02-14 | ↗ |
| 19 | Identification #52-2069785 (formerly 13-2631108) | 942.0K | 11.00% | 942.0K | — | — | 942.0K | IA | Delaware | 2016-02-03 | ↗ |
| 20 | HealthCor Management, L.P. | 771.1K | 1.80% | — | 771.1K | — | 771.1K | PN | Delaware | 2020-02-14 | ↗ |
| 21 | Olympia Investors, L.P. | 32.1K | 8.02% | — | 2.16M | — | 2.16M | PN | Delaware | 2017-04-17 | ↗ |
| 22 | Point72 Asia (Hong Kong) Limited | 1.8K | 4.00% | — | 1.8K | — | — | OO | Delaware | 2017-08-22 | ↗ |
| 23 | Macquarie Investment Management Group Limited | 1.4K | 0.00% | 1.4K | — | 1.4K | — | CO | — | 2021-02-12 | ↗ |
| 24 | Cubist Systematic Strategies, LLC | 619.00 | 4.00% | — | 619.00 | — | — | OO | Delaware | 2017-08-22 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
30
-236 vs prev Q
New positions
2
Closed positions
234
Increased
15
Reduced
8
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | BLACKROCK, INC. | 7.06M -271.9K (-3.7%) | 182.82M -6.2M (-3.3%) | 16.04% -0.097 pp | 0.00% 0.000 pp | USD15.21 +70.2% | 6 qtrs — |
| 2 | VANGUARD GROUP INC | 4.81M -384.6K (-7.4%) | 124.56M -9.4M (-7.0%) | 10.93% -0.504 pp | 0.00% 0.000 pp | USD44.57 -41.9% | 58 qtrs — |
| 3 | DOMA PERPETUAL CAPITAL MANAGEMENT LLC | 2.78M +76.5K (+2.8%) | 71.89M +2.3M (+3.3%) | 6.31% +0.365 pp | 20.21% -3.162 pp | USD24.29 +6.5% | 9 qtrs — |
| 4 | D. E. SHAW & CO., INC. | 2.04M +97.8K (+5.0%) | 52.79M +2.7M (+5.5%) | 4.63% +0.360 pp | 0.03% +0.001 pp | USD19.07 +35.7% | 12 qtrs — |
| 5 | DIMENSIONAL FUND ADVISORS LP | 1.95M -213.5K (-9.9%) | 50.47M -5.3M (-9.5%) | 4.43% -0.331 pp | 0.01% -0.001 pp | USD37.58 -31.1% | 30 qtrs — |
| 6 | RENAISSANCE TECHNOLOGIES LLC | 1.88M -254.2K (-11.9%) | 48.76M -6.3M (-11.5%) | 4.28% -0.426 pp | 0.08% +0.003 pp | USD36.65 -29.4% | 30 qtrs — |
| 7 | STATE STREET CORP | 1.88M -17.2K (-0.9%) | 48.74M -235.8K (-0.5%) | 4.28% +0.096 pp | 0.00% 0.000 pp | USD41.63 -37.8% | 51 qtrs — |
| 8 | AMERICAN CENTURY COMPANIES INC | 1.34M -42.5K (-3.1%) | 34.58M -947.4K (-2.7%) | 3.03% +0.001 pp | 0.02% -0.001 pp | USD24.71 +4.7% | 11 qtrs — |
| 9 | GOLDMAN SACHS GROUP INC | 1.30M -9.6K (-0.7%) | 33.65M -104.4K (-0.3%) | 2.95% +0.071 pp | 0.00% +0.000 pp | USD26.45 -2.2% | 55 qtrs — |
| 10 | MORGAN STANLEY | 1.19M +49.8K (+4.4%) | 30.86M +1.4M (+4.8%) | 2.71% +0.194 pp | 0.00% +0.000 pp | USD25.47 +1.6% | 51 qtrs — |
| 11 | GEODE CAPITAL MANAGEMENT, LLC | 1.17M -46.3K (-3.8%) | 30.27M -1.1M (-3.4%) | 2.66% -0.019 pp | 0.00% 0.000 pp | USD40.96 -36.8% | 60 qtrs — |
| 12 | BALYASNY ASSET MANAGEMENT L.P. | 946.0K -939.1K (-49.8%) | 24.48M -24.1M (-49.6%) | 2.15% -1.999 pp | 0.03% -0.031 pp | USD23.37 +10.7% | 5 qtrs — |
| 13 | CITADEL ADVISORS LLC | 819.8K +748.6K (+1,051.7%) | 21.22M +19.4M (+1,056.6%) | 1.86% +1.705 pp | 0.00% +0.003 pp | USD25.87 +0.0% | 51 qtrs — |
| 14 | IMPAX ASSET MANAGEMENT GROUP PLC | 750.0K +150.0K (+25.0%) | 19.41M +3.9M (+25.5%) | 1.70% +0.383 pp | 0.12% +0.031 pp | USD32.10 -19.4% | 20 qtrs — |
| 15 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 676.4K +49.1K (+7.8%) | 17.50M +1.3M (+8.3%) | 1.54% +0.156 pp | 0.00% +0.000 pp | USD34.87 -25.8% | 55 qtrs — |
| 16 | UBS GROUP AG | 558.7K -296.2K (-34.7%) | 14.46M -7.6M (-34.4%) | 1.27% -0.612 pp | 0.00% -0.001 pp | USD21.99 +17.7% | 45 qtrs — |
| 17 | NORTHERN TRUST CORP | 528.5K -45.8K (-8.0%) | 13.68M -1.1M (-7.6%) | 1.20% -0.063 pp | 0.00% 0.000 pp | USD39.17 -33.9% | 51 qtrs — |
| 18 | WELLINGTON MANAGEMENT GROUP LLP | 518.5K -10.0K (-1.9%) | 13.42M -200.1K (-1.5%) | 1.18% +0.015 pp | 0.00% +0.000 pp | USD45.28 -42.8% | 17 qtrs — |
| 19 | GAGNON SECURITIES LLC | 501.2K +51.5K (+11.5%) | 12.97M +1.4M (+11.9%) | 1.14% +0.149 pp | 2.64% +0.317 pp | USD36.83 -29.7% | 27 qtrs — |
| 20 | TWO SIGMA INVESTMENTS, LP | 451.9K +218.9K (+93.9%) | 11.69M +5.7M (+94.8%) | 1.03% +0.514 pp | 0.02% +0.008 pp | USD26.16 -1.1% | 12 qtrs — |
| 21 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 441.2K -3.5K (-0.8%) | 11.42M -42.5K (-0.4%) | 1.00% +0.024 pp | 0.24% -0.005 pp | USD17.24 +50.1% | 6 qtrs — |
| 22 | J. GOLDMAN & CO LP | 437.3K -231.9K (-34.7%) | 11.32M -5.9M (-34.4%) | 0.99% -0.479 pp | 0.30% -0.136 pp | USD23.99 +7.9% | 5 qtrs — |
| 23 | ASSENAGON ASSET MANAGEMENT S.A. | 435.1K +202.8K (+87.3%) | 11.26M +5.3M (+88.1%) | 0.99% +0.477 pp | 0.02% +0.007 pp | USD23.64 +9.5% | 12 qtrs — |
| 24 | DEUTSCHE BANK AG\ | 387.5K +1.6K (+0.4%) | 10.03M +84.5K (+0.8%) | 0.88% +0.031 pp | 0.00% 0.000 pp | USD24.80 +4.4% | 50 qtrs — |
| 25 | JANE STREET GROUP, LLC | 386.0K +239.3K (+163.2%) | 9.99M +6.2M (+164.3%) | 0.88% +0.554 pp | 0.00% +0.001 pp | USD25.16 +2.9% | 25 qtrs — |
| 26 | BARCLAYS PLC | 349.4K -56.0K (-13.8%) | 9.04M +2.9M (+48.2%) | 0.79% -0.099 pp | 0.00% +0.001 pp | USD29.04 -10.9% | 51 qtrs — |
| 27 | VICTORY CAPITAL MANAGEMENT INC | 342.3K +55.9K (+19.5%) | 8.86M +1.5M (+20.0%) | 0.78% +0.147 pp | 0.01% +0.001 pp | USD30.03 -13.8% | 26 qtrs — |
| 28 | BANK OF NEW YORK MELLON CORP | 329.6K -37.0K (-10.1%) | 8.53M -917.9K (-9.7%) | 0.75% -0.058 pp | 0.00% 0.000 pp | USD47.52 -45.5% | 58 qtrs — |
| 29 | LSV ASSET MANAGEMENT | 319.8K +205.5K (+179.8%) | 8.28M +5.3M (+180.9%) | 0.73% +0.475 pp | 0.02% +0.012 pp | USD25.39 +1.9% | 7 qtrs — |
| 30 | HILLSDALE INVESTMENT MANAGEMENT INC. | 308.2K +308.2K (+100.0%) | 7.98M +8.0M (+100.0%) | 0.70% +0.700 pp | 0.22% +0.220 pp | USD25.88 +0.0% | 1 qtrs NEW |
| 31 | HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 303.8K +10.8K (+3.7%) | 7.86M +312.6K (+4.1%) | 0.69% +0.045 pp | 0.01% -0.001 pp | USD24.69 +4.8% | 3 qtrs — |
| 32 | JPMORGAN CHASE & CO | 288.7K -147.5K (-33.8%) | 7.47M -3.8M (-33.5%) | 0.66% -0.304 pp | 0.00% 0.000 pp | USD27.26 -5.1% | 51 qtrs — |
| 33 | BRIDGE CITY CAPITAL, LLC | 285.5K -26.0K (-8.3%) | 7.39M -637.4K (-7.9%) | 0.65% -0.037 pp | 2.17% +0.028 pp | USD22.71 +14.0% | 8 qtrs — |
| 34 | PRINCIPAL FINANCIAL GROUP INC | 261.4K +6.9K (+2.7%) | 6.76M +207.8K (+3.2%) | 0.59% +0.034 pp | 0.00% +0.000 pp | USD39.71 -34.8% | 36 qtrs — |
| 35 | GAGNON ADVISORS, LLC | 260.9K +47.5K (+22.3%) | 6.75M +1.3M (+22.8%) | 0.59% +0.123 pp | 4.29% +0.891 pp | USD34.85 -25.7% | 27 qtrs — |
| 36 | NUVEEN, LLC | 252.0K -11.8K (-4.5%) | 6.52M -276.4K (-4.1%) | 0.57% -0.008 pp | 0.00% 0.000 pp | USD24.85 +4.1% | 4 qtrs — |
| 37 | EASTERLY INVESTMENT PARTNERS LLC | 251.9K +2.7K (+1.1%) | 6.52M +98.4K (+1.5%) | 0.57% +0.024 pp | 0.40% -0.034 pp | USD25.84 +0.2% | 10 qtrs — |
| 38 | INVESCO LTD. | 244.7K -272.7K (-52.7%) | 6.33M -7.0M (-52.5%) | 0.56% -0.583 pp | 0.00% -0.001 pp | USD28.67 -9.7% | 52 qtrs — |
| 39 | VOLORIDGE INVESTMENT MANAGEMENT, LLC | 234.4K -28.3K (-10.8%) | 6.07M -703.0K (-10.4%) | 0.53% -0.046 pp | 0.02% -0.001 pp | USD25.19 +2.7% | 10 qtrs — |
| 40 | EMPOWERED FUNDS, LLC | 227.6K +4.2K (+1.9%) | 5.89M +132.4K (+2.3%) | 0.52% +0.025 pp | 0.05% -0.011 pp | USD15.79 +63.9% | 6 qtrs — |
| 41 | PACER ADVISORS, INC. | 189.1K -11.1K (-5.5%) | 4.90M -264.2K (-5.1%) | 0.43% -0.011 pp | 0.01% -0.001 pp | USD22.08 +17.2% | 11 qtrs — |
| 42 | PUBLIC SECTOR PENSION INVESTMENT BOARD | 188.9K -16.1K (-7.8%) | 4.89M -392.9K (-7.4%) | 0.43% -0.022 pp | 0.02% -0.003 pp | USD29.80 -13.2% | 26 qtrs — |
| 43 | FIRST TRUST ADVISORS LP | 188.9K +179.1K (+1,838.9%) | 4.89M +4.6M (+1,847.2%) | 0.43% +0.408 pp | 0.00% +0.003 pp | USD25.87 +0.0% | 29 qtrs — |
| 44 | ROYAL BANK OF CANADA | 187.4K -183.3K (-49.4%) | 4.85M -4.7M (-49.2%) | 0.43% -0.390 pp | 0.00% -0.001 pp | USD27.37 -5.4% | 51 qtrs — |
| 45 | BANK OF AMERICA CORP /DE/ | 184.8K +25.3K (+15.9%) | 4.78M +672.6K (+16.4%) | 0.42% +0.069 pp | 0.00% +0.000 pp | USD29.37 -11.9% | 52 qtrs — |
| 46 | AMERIPRISE FINANCIAL INC | 183.6K -19.6K (-9.7%) | 4.75M -485.5K (-9.3%) | 0.42% -0.030 pp | 0.00% 0.000 pp | USD30.66 -15.6% | 51 qtrs — |
| 47 | RICE HALL JAMES & ASSOCIATES, LLC | 181.3K -55.8K (-23.5%) | 4.69M -1.4M (-23.2%) | 0.41% -0.110 pp | 0.26% -0.075 pp | USD42.13 -38.6% | 43 qtrs — |
| 48 | JEFFERIES FINANCIAL GROUP INC. | 172.1K +123.8K (+256.4%) | 4.45M +3.2M (+257.9%) | 0.39% +0.285 pp | 0.02% +0.017 pp | USD25.38 +2.0% | 13 qtrs — |
| 49 | JACOBS LEVY EQUITY MANAGEMENT, INC | 170.5K -482.1K (-73.9%) | 4.41M -12.4M (-73.8%) | 0.39% -1.048 pp | 0.02% -0.050 pp | USD21.95 +17.9% | 5 qtrs — |
| 50 | PDT PARTNERS, LLC | 169.6K -4.2K (-2.4%) | 4.39M -89.6K (-2.0%) | 0.39% +0.003 pp | 0.28% +0.002 pp | USD15.33 +68.8% | 6 qtrs — |
| 51 | INTECH INVESTMENT MANAGEMENT LLC | 166.7K +103.6K (+164.1%) | 4.31M +2.7M (+165.2%) | 0.38% +0.240 pp | 0.04% +0.024 pp | USD24.82 +4.3% | 6 qtrs — |
| 52 | PRUDENTIAL FINANCIAL INC | 160.5K +11.0K (+7.4%) | 4.15M +301.8K (+7.8%) | 0.36% +0.036 pp | 0.01% +0.000 pp | USD25.28 +2.4% | 30 qtrs — |
| 53 | STATE OF WISCONSIN INVESTMENT BOARD | 160.2K +5.6K (+3.6%) | 4.15M +161.3K (+4.0%) | 0.36% +0.024 pp | 0.01% +0.000 pp | USD27.07 -4.4% | 35 qtrs — |
| 54 | BANCO SANTANDER, S.A. | 156.0K +3.0K (+2.0%) | 4.04M +94.5K (+2.4%) | 0.35% +0.018 pp | 0.03% -0.005 pp | USD27.38 -5.5% | 7 qtrs — |
| 55 | PHOCAS FINANCIAL CORP. | 146.5K -368.0 (-0.3%) | 3.79M +6.6K (+0.2%) | 0.33% +0.010 pp | 0.49% +0.002 pp | USD24.60 +5.2% | 4 qtrs — |
| 56 | HENNION & WALSH ASSET MANAGEMENT, INC. | 138.1K +87.2K (+171.4%) | 3.57M +2.3M (+172.5%) | 0.31% +0.202 pp | 0.12% +0.076 pp | USD25.21 +2.7% | 7 qtrs — |
| 57 | AQR CAPITAL MANAGEMENT LLC | 137.2K -3.2K (-2.3%) | 3.55M -66.5K (-1.8%) | 0.31% +0.003 pp | 0.00% -0.001 pp | USD17.36 +49.1% | 12 qtrs — |
| 58 | RHUMBLINE ADVISERS | 127.9K -16.5K (-11.4%) | 3.31M -409.9K (-11.0%) | 0.29% -0.027 pp | 0.00% 0.000 pp | USD42.99 -39.8% | 51 qtrs — |
| 59 | HUSSMAN STRATEGIC ADVISORS, INC. | 126.0K +21.0K (+20.0%) | 3.26M +555.0K (+20.5%) | 0.29% +0.055 pp | 0.79% +0.202 pp | USD25.79 +0.3% | 2 qtrs — |
| 60 | MILLENNIUM MANAGEMENT LLC | 122.6K +51.8K (+73.3%) | 3.17M +1.3M (+74.0%) | 0.28% +0.123 pp | 0.00% +0.001 pp | USD22.18 +16.7% | 56 qtrs — |
| 61 | BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 117.8K +117.4K (+27,551.4%) | 3.05M +3.0M (+27,609.1%) | 0.27% +0.267 pp | 0.00% +0.004 pp | USD25.87 +0.0% | 3 qtrs — |
| 62 | HRT FINANCIAL LP | 116.4K +7.9K (+7.3%) | 3.01M +218.0K (+7.8%) | 0.26% +0.026 pp | 0.01% -0.001 pp | USD25.78 +0.4% | 5 qtrs — |
| 63 | LEGAL & GENERAL GROUP PLC | 111.8K -5.7K (-4.8%) | 2.89M -134.1K (-4.4%) | 0.25% -0.005 pp | 0.00% +0.000 pp | USD44.42 -41.7% | 46 qtrs — |
| 64 | BNP PARIBAS ARBITRAGE, SNC | 111.5K +28.3K (+34.0%) | 2.89M +740.7K (+34.5%) | 0.25% +0.070 pp | 0.00% +0.000 pp | USD24.99 +3.6% | 51 qtrs — |
| 65 | CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 105.1K +105.1K (+100.0%) | 2.72M +2.7M (+100.0%) | 0.24% +0.239 pp | 0.01% +0.007 pp | USD25.88 +0.0% | 1 qtrs NEW |
| 66 | TWO SIGMA ADVISERS, LP | 94.8K +30.1K (+46.5%) | 2.45M +786.1K (+47.1%) | 0.22% +0.073 pp | 0.00% +0.001 pp | USD23.02 +12.4% | 12 qtrs — |
| 67 | NEW YORK STATE COMMON RETIREMENT FUND | 91.2K -146.0 (-0.2%) | 2.36M +6.3K (+0.3%) | 0.21% +0.006 pp | 0.00% +0.000 pp | USD36.69 -29.5% | 47 qtrs — |
| 68 | SIMPLIFY ASSET MANAGEMENT INC. | 86.3K +41.3K (+91.9%) | 2.23M +1.1M (+92.7%) | 0.20% +0.097 pp | 0.04% +0.015 pp | USD24.46 +5.8% | 5 qtrs — |
| 69 | VERITION FUND MANAGEMENT LLC | 85.4K +85.4K (+100.0%) | 2.21M +2.2M (+100.0%) | 0.19% +0.194 pp | 0.01% +0.009 pp | USD25.88 +0.0% | 6 qtrs — |
| 70 | SWISS NATIONAL BANK | 84.2K -5.6K (-6.2%) | 2.18M -135.1K (-5.8%) | 0.19% -0.006 pp | 0.00% +0.000 pp | USD50.65 -48.9% | 51 qtrs — |
| 71 | XTX TOPCO LTD | 82.9K +82.9K (+100.0%) | 2.15M +2.1M (+100.0%) | 0.19% +0.188 pp | 0.06% +0.056 pp | USD25.88 +0.0% | 1 qtrs NEW |
| 72 | CAMPBELL & CO INVESTMENT ADVISER LLC | 78.3K +78.3K (+100.0%) | 2.03M +2.0M (+100.0%) | 0.18% +0.178 pp | 0.10% +0.097 pp | USD25.88 +0.0% | 1 qtrs NEW |
| 73 | EXCHANGE TRADED CONCEPTS, LLC | 76.8K +1.2K (+1.6%) | 1.99M +40.4K (+2.1%) | 0.17% +0.008 pp | 0.02% -0.001 pp | USD25.77 +0.4% | 2 qtrs — |
| 74 | FMR LLC | 73.9K -27.9K (-27.4%) | 1.91M -711.6K (-27.1%) | 0.17% -0.056 pp | 0.00% +0.000 pp | USD34.56 -25.1% | 25 qtrs — |
| 75 | UBS ASSET MANAGEMENT AMERICAS INC | 73.5K -2.8K (-3.7%) | 1.90M -64.9K (-3.3%) | 0.17% -0.001 pp | 0.00% +0.000 pp | USD29.43 -12.1% | 53 qtrs — |
| 76 | LPL FINANCIAL LLC | 73.4K +47.2K (+180.1%) | 1.90M +1.2M (+181.3%) | 0.17% +0.109 pp | 0.00% +0.000 pp | USD24.87 +4.1% | 9 qtrs — |
| 77 | — | 71.3K +71.3K (+100.0%) | 1.85M +1.8M (+100.0%) | 0.16% +0.162 pp | 0.25% +0.251 pp | USD25.88 +0.0% | 1 qtrs NEW |
| 78 | GREAT LAKES ADVISORS, LLC | 70.3K -35.5K (-33.5%) | 1.82M -906.1K (-33.3%) | 0.16% -0.073 pp | 0.01% -0.008 pp | USD15.05 +72.0% | 6 qtrs — |
| 79 | UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH | 69.1K +54.1K (+360.1%) | 1.79M +1.4M (+362.1%) | 0.16% +0.124 pp | 0.00% +0.002 pp | USD25.63 +1.0% | 4 qtrs — |
| 80 | GLOBAL ALPHA CAPITAL MANAGEMENT LTD. | 68.4K -11.1K (-14.0%) | 1.77M -278.5K (-13.6%) | 0.16% -0.020 pp | 0.11% -0.009 pp | USD28.23 -8.3% | 9 qtrs — |
| 81 | MARTINGALE ASSET MANAGEMENT L P | 68.2K -10.5K (-13.3%) | 1.77M -263.0K (-13.0%) | 0.15% -0.018 pp | 0.04% -0.006 pp | USD24.63 +5.1% | 4 qtrs — |
| 82 | QUANTBOT TECHNOLOGIES LP | 67.2K +46.8K (+229.5%) | 1.74M +1.2M (+230.9%) | 0.15% +0.108 pp | 0.06% +0.044 pp | USD25.85 +0.1% | 15 qtrs — |
| 83 | INTEGRATED QUANTITATIVE INVESTMENTS LLC | 64.8K +64.8K (+100.0%) | 1.68M +1.7M (+100.0%) | 0.15% +0.147 pp | 0.36% +0.360 pp | USD25.88 +0.0% | 5 qtrs — |
| 84 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 58.7K +3.4K (+6.1%) | 1.52M +94.1K (+6.6%) | 0.13% +0.012 pp | 0.00% +0.000 pp | USD25.10 +3.1% | 51 qtrs — |
| 85 | SQUAREPOINT OPS LLC | 57.3K +5.0K (+9.5%) | 1.48M +135.1K (+10.0%) | 0.13% +0.015 pp | 0.00% +0.000 pp | USD25.08 +3.2% | 8 qtrs — |
| 86 | ENGINEERS GATE MANAGER LP | 56.5K +8.7K (+18.2%) | 1.46M +230.1K (+18.7%) | 0.13% +0.023 pp | 0.02% +0.003 pp | USD22.46 +15.2% | 13 qtrs — |
| 87 | ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. | 54.0K +— (+0.0%) | 1.40M +5.9K (+0.4%) | 0.12% +0.004 pp | 0.00% +0.000 pp | USD16.56 +56.3% | 6 qtrs — |
| 88 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 53.2K +11.4K (+27.3%) | 1.38M +299.8K (+27.8%) | 0.12% +0.029 pp | 0.00% +0.000 pp | USD19.03 +36.0% | 7 qtrs — |
| 89 | ALLIANCEBERNSTEIN L.P. | 52.8K -14.0 (0.0%) | 1.37M +5.5K (+0.4%) | 0.12% +0.004 pp | 0.00% +0.000 pp | USD39.15 -33.9% | 55 qtrs — |
| 90 | WELLS FARGO & COMPANY/MN | 52.5K +15.3K (+41.2%) | 1.36M +400.2K (+41.8%) | 0.12% +0.037 pp | 0.00% +0.000 pp | USD29.02 -10.8% | 56 qtrs — |
| 91 | PRICE T ROWE ASSOCIATES INC /MD/ | 52.0K +2.0K (+4.0%) | 1.35M +57.0K (+4.4%) | 0.12% +0.008 pp | 0.00% +0.000 pp | USD28.57 -9.4% | 60 qtrs — |
| 92 | MILESTONE ASSET MANAGEMENT, LLC | 51.1K +51.1K (+100.0%) | 1.32M +1.3M (+100.0%) | 0.12% +0.116 pp | 0.25% +0.250 pp | USD25.88 +0.0% | 1 qtrs NEW |
| 93 | RUSSELL INVESTMENTS GROUP, LTD. | 50.5K -50.6K (-50.0%) | 1.31M -1.3M (-49.8%) | 0.11% -0.108 pp | 0.00% -0.002 pp | USD22.41 +15.5% | 37 qtrs — |
| 94 | CAXTON ASSOCIATES LLP | 50.0K +4.5K (+9.9%) | 1.29M +121.9K (+10.4%) | 0.11% +0.014 pp | 0.03% -0.002 pp | USD24.94 +3.8% | 4 qtrs — |
| 95 | DIADEMA PARTNERS LP | 48.0K -10.9K (-18.5%) | 1.24M -275.6K (-18.2%) | 0.11% -0.021 pp | 0.21% -0.174 pp | USD24.53 +5.5% | 4 qtrs — |
| 96 | LEGATO CAPITAL MANAGEMENT LLC | 47.2K -9.2K (-16.4%) | 1.22M -233.0K (-16.0%) | 0.11% -0.017 pp | 0.11% -0.053 pp | USD27.93 -7.3% | 10 qtrs — |
| 97 | PRELUDE CAPITAL MANAGEMENT, LLC | 44.0K +7.5K (+20.4%) | 1.14M +197.1K (+20.9%) | 0.10% +0.020 pp | 0.08% +0.010 pp | USD27.02 -4.2% | 11 qtrs — |
| 98 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 42.5K -124.0 (-0.3%) | 1.10M +1.5K (+0.1%) | 0.10% +0.003 pp | 0.00% +0.000 pp | USD47.38 -45.4% | 52 qtrs — |
| 99 | FOSTER & MOTLEY INC | 41.1K +26.0K (+172.4%) | 1.06M +675.0K (+174.0%) | 0.09% +0.060 pp | 0.06% +0.036 pp | USD25.84 +0.2% | 2 qtrs — |
| 100 | RADCLIFFE CAPITAL MANAGEMENT, L.P. | 39.8K -7.8K (-16.3%) | 1.03M -195.5K (-15.9%) | 0.09% -0.014 pp | 0.06% -0.020 pp | USD25.77 +0.4% | 2 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 155 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Pharmaceuticals ETF XPH | 1.58% | 7.43M | 0.35% |
| 2 | ETC 6 Meridian Small Cap Equity ETF SIXS | 1.16% | 1.23M | 0.52% |
| 3 | Pacer US Small Cap Cash Cows Growth Leaders ETF CAFG | 0.71% | 214.5K | 0.59% |
| 4 | Simplify Health Care ETF PINK | 0.59% | 2.23M | 0.51% |
| 5 | Invesco NASDAQ Future Gen 200 ETF QQQS | 0.55% | 120.3K | 0.20% |
| 6 | Distillate Small/Mid Cash Flow ETF DSMC | 0.52% | 686.5K | 0.55% |
| 7 | VictoryShares Small Cap Free Cash Flow ETF SFLO | 0.47% | 2.99M | 0.56% |
| 8 | ETC 6 Meridian Low Beta Equity ETF SIXL | 0.46% | 851.9K | 0.47% |
| 9 | Invesco S&P SmallCap 600 Revenue ETF RZG | 0.45% | 648.2K | 0.35% |
| 10 | Invesco S&P SmallCap Health Care ETF PSCH | 0.44% | 716.3K | 0.29% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.57
Neutral
Ratio by volume
0.53
Neutral
Buys
4
Sells
7
Shares acquired
25.0K
Shares disposed
47.2K
Cash buys
—
Cash sales
3.00
Net activity
-22,155
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-23 | Cross Shawn | Officer | M-Exempt | D | Stock Option (Right to Buy) | 12,941 | 16.45 | 212.9K | 150,000 | D | ↗ |
| 2026-04-22 | Cross Shawn | Officer | M-Exempt | D | Stock Option (Right to Buy) | 1,500 | 16.45 | 24.7K | 162,941 | D | ↗ |
| 2026-04-21 | Cross Shawn | Officer | M-Exempt | D | Stock Option (Right to Buy) | 2,845 | 16.45 | 46.8K | 164,441 | D | ↗ |
| 2026-04-20 | Cross Shawn | Officer | M-Exempt | D | Stock Option (Right to Buy) | 7,714 | 16.45 | 126.9K | 167,286 | D | ↗ |
| 2026-03-17 | SLONIN JONATHAN | Officer | S-Sale | D | Common Stock | 3,261 | 22.82 | 74.4K | 223,640 | D | ↗ |
| 2026-03-17 | Froimson Mark | Director | S-Sale | D | Common Stock | 500 | 21.81 | 10.9K | 20,136 | D | ↗ |
| 2026-02-11 | WILLIAMS KRISTEN | Officer | A-Award | A | Common Stock | 54,546 | 0.00 | — | 185,849 | D | ↗ |
| 2026-02-11 | Teehan Brendan | Officer | A-Award | A | Common Stock | 51,714 | 0.00 | — | 100,934 | D | ↗ |
| 2026-02-11 | SLONIN JONATHAN | Officer | A-Award | A | Common Stock | 54,546 | 0.00 | — | 226,901 | D | ↗ |
| 2026-02-11 | RIKER LAUREN | Officer | A-Award | A | Common Stock | 19,273 | 0.00 | — | 71,586 | D | ↗ |
| 2026-02-11 | Lee Frank D. | Director / Officer | A-Award | A | Common Stock | 261,818 | 0.00 | — | 660,831 | D | ↗ |
| 2026-02-11 | Cross Shawn | Officer | A-Award | A | Common Stock | 49,091 | 0.00 | — | 105,341 | D | ↗ |
| 2026-02-02 | WILLIAMS KRISTEN | Officer | S-Sale | D | Common Stock | 13,137 | 20.53 | 269.7K | 131,303 | D | ↗ |
| 2026-02-02 | RIKER LAUREN | Officer | S-Sale | D | Common Stock | 4,000 | 20.81 | 83.2K | 52,313 | D | ↗ |
| 2026-01-30 | WILLIAMS KRISTEN | Officer | F-InKind | D | Common Stock | 17,134 | 20.54 | 351.9K | 144,440 | D | ↗ |
| 2026-01-30 | Teehan Brendan | Officer | F-InKind | D | Common Stock | 5,182 | 20.54 | 106.4K | 49,220 | D | ↗ |
| 2026-01-30 | SLONIN JONATHAN | Officer | F-InKind | D | Common Stock | 6,168 | 20.54 | 126.7K | 172,355 | D | ↗ |
| 2026-01-30 | RIKER LAUREN | Officer | F-InKind | D | Common Stock | 2,751 | 20.54 | 56.5K | 56,313 | D | ↗ |
| 2026-01-30 | Lee Frank D. | Director / Officer | F-InKind | D | Common Stock | 41,488 | 20.54 | 852.2K | 399,013 | D | ↗ |
| 2026-01-27 | Hirawat Samit | Director | A-Award | A | Stock Option (Right to Buy) | 39,291 | 19.85 | 779.9K | 39,291 | D | ↗ |
| 2026-01-05 | RIKER LAUREN | Officer | S-Sale | D | Common Stock | 1,416 | 24.24 | 34.3K | 59,064 | D | ↗ |
| 2026-01-02 | SLONIN JONATHAN | Officer | F-InKind | D | Common Stock | 381 | 24.46 | 9.3K | 178,523 | D | ↗ |
| 2026-01-02 | RIKER LAUREN | Officer | F-InKind | D | Common Stock | 159 | 24.46 | 3.9K | 60,480 | D | ↗ |
| 2026-01-02 | Lee Frank D. | Director / Officer | F-InKind | D | Common Stock | 9,272 | 24.46 | 226.8K | 440,501 | D | ↗ |
| 2025-12-31 | Teehan Brendan | Officer | A-Award | A | Common Stock | 402 | 10.76 | 4.3K | 54,402 | D | ↗ |
| 2025-12-10 | Cross Shawn | Officer | M-Exempt | D | Stock Option (Right to Buy) | 9,104 | 16.45 | 149.8K | 175,000 | D | ↗ |
| 2025-12-09 | Cross Shawn | Officer | M-Exempt | D | Stock Option (Right to Buy) | 15,896 | 16.45 | 261.5K | 184,104 | D | ↗ |
| 2025-11-17 | SLONIN JONATHAN | Officer | S-Sale | D | Common Stock | 3,960 | 24.09 | 95.4K | 178,367 | D | ↗ |
| 2025-11-10 | Cross Shawn | Officer | S-Sale | D | Common Stock | 12,060 | 22.09 | 266.4K | 56,250 | D | ↗ |
| 2025-10-31 | Cross Shawn | Officer | F-InKind | D | Common Stock | 6,690 | 21.38 | 143.0K | 68,310 | D | ↗ |
| 2025-09-04 | Ceesay Abraham | Director | S-Sale | D | Common Stock | 2,354 | 27.19 | 64.0K | 9,039 | D | ↗ |
| 2025-08-07 | BIGAL MARCELO | Director | S-Sale | D | Common Stock | 4,912 | 23.67 | 116.3K | 11,393 | D | ↗ |
| 2025-08-01 | SLONIN JONATHAN | Officer | F-InKind | D | Common Stock | 315 | 22.07 | 7.0K | 182,327 | D | ↗ |
| 2025-06-11 | Young Alethia | Director | A-Award | A | Stock Option (Right to Buy) | 11,279 | 24.34 | 274.5K | 11,279 | D | ↗ |
| 2025-06-11 | YANG MICHAEL J. | Director | A-Award | A | Stock Option (Right to Buy) | 11,279 | 24.34 | 274.5K | 11,279 | D | ↗ |
| 2025-06-11 | Kronenfeld Mark A. | Director | A-Award | A | Stock Option (Right to Buy) | 11,279 | 24.34 | 274.5K | 11,279 | D | ↗ |
| 2025-06-11 | Froimson Mark | Director | A-Award | A | Stock Option (Right to Buy) | 11,279 | 24.34 | 274.5K | 11,279 | D | ↗ |
| 2025-06-11 | Ceesay Abraham | Director | A-Award | A | Stock Option (Right to Buy) | 11,279 | 24.34 | 274.5K | 11,279 | D | ↗ |
| 2025-06-11 | CHRISTIE CHRISTOPHER | Director | A-Award | A | Stock Option (Right to Buy) | 11,279 | 24.34 | 274.5K | 11,279 | D | ↗ |
| 2025-06-11 | Brege Laura | Director | A-Award | A | Stock Option (Right to Buy) | 11,279 | 24.34 | 274.5K | 11,279 | D | ↗ |
| 2025-06-11 | BIGAL MARCELO | Director | A-Award | A | Stock Option (Right to Buy) | 11,279 | 24.34 | 274.5K | 11,279 | D | ↗ |
| 2025-06-04 | WILLIAMS KRISTEN | Officer | S-Sale | D | Common Stock | 14,376 | 26.24 | 377.2K | 161,574 | D | ↗ |
| 2025-06-04 | RIKER LAUREN | Officer | S-Sale | D | Common Stock | 5,578 | 26.21 | 146.2K | 59,564 | D | ↗ |
| 2025-06-03 | WILLIAMS KRISTEN | Officer | F-InKind | D | Common Stock | 6,162 | 26.40 | 162.7K | 175,950 | D | ↗ |
| 2025-06-03 | SLONIN JONATHAN | Officer | F-InKind | D | Common Stock | 5,084 | 26.40 | 134.2K | 181,960 | D | ↗ |
| 2025-06-03 | RIKER LAUREN | Officer | F-InKind | D | Common Stock | 3,374 | 26.40 | 89.1K | 65,142 | D | ↗ |
| 2025-02-04 | Teehan Brendan | Officer | A-Award | A | Stock Option (Right to Buy) | 99,500 | 26.59 | 2.65M | 99,500 | D | ↗ |
| 2025-02-01 | WILLIAMS KRISTEN | Officer | A-Award | A | Common Stock | 79,200 | 0.00 | — | 182,112 | D | ↗ |
| 2025-02-01 | Teehan Brendan | Officer | A-Award | A | Common Stock | 54,000 | 0.00 | — | 54,000 | D | ↗ |
| 2025-02-01 | SLONIN JONATHAN | Officer | A-Award | A | Common Stock | 93,600 | 0.00 | — | 187,044 | D | ↗ |
| 2025-02-01 | RIKER LAUREN | Officer | A-Award | A | Common Stock | 30,600 | 0.00 | — | 68,516 | D | ↗ |
| 2025-02-01 | Lee Frank D. | Director / Officer | A-Award | A | Common Stock | 350,000 | 0.00 | — | 448,409 | D | ↗ |
| 2025-01-21 | Teehan Brendan | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-01-06 | SLONIN JONATHAN | Officer | S-Sale | D | Common Stock | 879 | 18.40 | 16.2K | 93,444 | D | ↗ |
| 2025-01-02 | SLONIN JONATHAN | Officer | F-InKind | D | Common Stock | 371 | 18.33 | 6.8K | 94,323 | D | ↗ |
| 2025-01-02 | RIKER LAUREN | Officer | F-InKind | D | Common Stock | 159 | 18.33 | 2.9K | 37,916 | D | ↗ |
| 2025-01-02 | Lee Frank D. | Director / Officer | F-InKind | D | Common Stock | 9,375 | 18.33 | 171.8K | 98,409 | D | ↗ |
| 2024-12-31 | GAUGLER DARYL | Officer | A-Award | A | Common Stock | 244 | 16.01 | 3.9K | 115,443 | D | ↗ |
| 2024-12-13 | GAUGLER DARYL | Officer | S-Sale | D | Common Stock | 500 | 19.76 | 9.9K | 115,200 | D | ↗ |
| 2024-11-04 | Cross Shawn | Officer | A-Award | A | Stock Option (Right to Buy) | 200,000 | 16.45 | 3.29M | 200,000 | D | ↗ |
| 2024-11-01 | Cross Shawn | Officer | A-Award | A | Common Stock | 75,000 | 0.00 | — | 75,000 | D | ↗ |
| 2024-10-21 | Cross Shawn | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-09-13 | GAUGLER DARYL | Officer | S-Sale | D | Common Stock | 500 | 12.86 | 6.4K | 115,700 | — | ↗ |
| 2024-08-16 | Brege Laura | Director | P-Purchase | A | Common Stock | 1,000 | 12.81 | 12.8K | 17,552 | — | ↗ |
| 2024-08-16 | BIGAL MARCELO | Director | P-Purchase | A | Common Stock | 1,512 | 13.25 | 20.0K | 10,142 | — | ↗ |
| 2024-08-14 | YANG MICHAEL J. | Director | P-Purchase | A | Common Stock | 2,000 | 12.90 | 25.8K | 7,230 | — | ↗ |
| 2024-08-12 | Lee Frank D. | Director / Officer | P-Purchase | A | Common Stock | 8,264 | 12.10 | 100.0K | 107,784 | — | ↗ |
| 2024-08-12 | Froimson Mark | Director | P-Purchase | A | Common Stock | 1,400 | 11.58 | 16.2K | 14,473 | — | ↗ |
| 2024-08-12 | BIGAL MARCELO | Director | P-Purchase | A | Common Stock | 3,400 | 12.01 | 40.8K | 8,630 | — | ↗ |
| 2024-08-02 | SLONIN JONATHAN | Officer | S-Sale | D | Common Stock | 945 | 20.05 | 18.9K | 94,307 | — | ↗ |
| 2024-08-01 | SLONIN JONATHAN | Officer | F-InKind | D | Common Stock | 305 | 20.75 | 6.3K | 95,252 | — | ↗ |
| 2024-07-02 | SLONIN JONATHAN | Officer | S-Sale | D | Common Stock | 2,836 | 28.25 | 80.1K | 95,557 | — | ↗ |
| 2024-07-01 | SLONIN JONATHAN | Officer | F-InKind | D | Common Stock | 914 | 28.46 | 26.0K | 98,393 | — | ↗ |
| 2024-06-28 | SLONIN JONATHAN | Officer | A-Award | A | Common Stock | 437 | 24.32 | 10.6K | 99,307 | — | ↗ |
| 2024-06-28 | GAUGLER DARYL | Officer | A-Award | A | Common Stock | 160 | 24.32 | 3.9K | 116,200 | — | ↗ |
| 2024-06-13 | WILLIAMS KRISTEN | Officer | S-Sale | D | Common Stock | 7,452 | 28.38 | 211.5K | 102,912 | — | ↗ |
| 2024-06-13 | HASTINGS PAUL J | Director | S-Sale | D | Common Stock | 880 | 28.38 | 25.0K | 12,724 | — | ↗ |
| 2024-06-13 | GAUGLER DARYL | Officer | S-Sale | D | Common Stock | 1,000 | 28.38 | 28.4K | 116,040 | — | ↗ |
| 2024-06-12 | Young Alethia | Director | A-Award | A | Stock Option (Right to Buy) | 12,179 | 28.68 | 349.3K | 12,179 | — | ↗ |
| 2024-06-12 | YANG MICHAEL J. | Director | A-Award | A | Stock Option (Right to Buy) | 12,179 | 28.68 | 349.3K | 12,179 | — | ↗ |
| 2024-06-12 | WILLIAMS KRISTEN | Officer | A-Award | A | Common Stock | 54,300 | 0.00 | — | 110,364 | — | ↗ |
| 2024-06-12 | SLONIN JONATHAN | Officer | A-Award | A | Common Stock | 54,300 | 0.00 | — | 98,869 | — | ↗ |
| 2024-06-12 | Reinhart Charles A. III | Officer | A-Award | A | Common Stock | 12,220 | 0.00 | — | 51,867 | — | ↗ |
| 2024-06-12 | RIKER LAUREN | Officer | S-Sale | D | Common Stock | 3,970 | 28.72 | 114.0K | 38,075 | — | ↗ |
| 2024-06-12 | Kronenfeld Mark A. | Director | A-Award | A | Common Stock | 5,230 | 0.00 | — | 24,902 | — | ↗ |
| 2024-06-12 | HASTINGS PAUL J | Director | A-Award | A | Stock Option (Right to Buy) | 12,179 | 28.68 | 349.3K | 12,179 | — | ↗ |
| 2024-06-12 | GAUGLER DARYL | Officer | A-Award | A | Common Stock | 54,300 | 0.00 | — | 117,040 | — | ↗ |
| 2024-06-12 | Froimson Mark | Director | A-Award | A | Stock Option (Right to Buy) | 12,179 | 28.68 | 349.3K | 12,179 | — | ↗ |
| 2024-06-12 | Ceesay Abraham | Director | A-Award | A | Common Stock | 5,230 | 0.00 | — | 5,230 | — | ↗ |
| 2024-06-12 | CHRISTIE CHRISTOPHER | Director | A-Award | A | Stock Option (Right to Buy) | 12,179 | 28.68 | 349.3K | 12,179 | — | ↗ |
| 2024-06-12 | Brege Laura | Director | A-Award | A | Stock Option (Right to Buy) | 12,179 | 28.68 | 349.3K | 12,179 | — | ↗ |
| 2024-06-12 | BIGAL MARCELO | Director | A-Award | A | Stock Option (Right to Buy) | 12,179 | 28.68 | 349.3K | 12,179 | — | ↗ |
| 2024-06-11 | SLONIN JONATHAN | Officer | S-Sale | D | Common Stock | 5,012 | 28.57 | 143.2K | 44,569 | — | ↗ |
| 2024-06-03 | WILLIAMS KRISTEN | Officer | F-InKind | D | Common Stock | 3,011 | 30.89 | 93.0K | 56,064 | — | ↗ |
| 2024-06-03 | SLONIN JONATHAN | Officer | F-InKind | D | Common Stock | 1,615 | 30.89 | 49.9K | 49,581 | — | ↗ |
| 2024-06-03 | Reinhart Charles A. III | Officer | F-InKind | D | Common Stock | 2,979 | 30.89 | 92.0K | 39,647 | — | ↗ |
| 2024-06-03 | RIKER LAUREN | Officer | F-InKind | D | Common Stock | 1,843 | 30.89 | 56.9K | 20,685 | — | ↗ |
| 2024-06-03 | GAUGLER DARYL | Officer | F-InKind | D | Common Stock | 2,754 | 30.89 | 85.1K | 62,740 | — | ↗ |
| 2024-03-08 | PACE GARY W | Director | S-Sale | D | Common Stock | 90,000 | 30.60 | 2.75M | 22,127 | — | ↗ |
| 2024-03-07 | PACE GARY W | Director | S-Sale | D | Common Stock | 28,257 | 30.81 | 870.6K | 112,127 | — | ↗ |
| 2024-03-06 | PACE GARY W | Director | S-Sale | D | Common Stock | 1,066 | 29.67 | 31.6K | 140,384 | — | ↗ |
| 2024-02-05 | WILLIAMS KRISTEN | Officer | A-Award | A | Common Stock | 33,700 | 0.00 | — | 59,075 | — | ↗ |
| 2024-02-05 | GAUGLER DARYL | Officer | A-Award | A | Common Stock | 33,700 | 0.00 | — | 65,494 | — | ↗ |
| 2024-01-03 | SLONIN JONATHAN | Officer | A-Award | A | Stock Option (Right to Buy) | 10,000 | 32.07 | 320.7K | 10,000 | — | ↗ |
| 2024-01-03 | Lee Frank D. | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 692,512 | 32.07 | 22.21M | 692,512 | — | ↗ |
| 2024-01-02 | SLONIN JONATHAN | Officer | A-Award | A | Common Stock | 5,000 | 0.00 | — | 51,196 | — | ↗ |
| 2024-01-02 | RIKER LAUREN | Officer | F-InKind | D | Common Stock | 159 | 32.00 | 5.1K | 22,528 | — | ↗ |
| 2024-01-02 | Lee Frank D. | Director / Officer | A-Award | A | Common Stock | 99,520 | 0.00 | — | 99,520 | — | ↗ |
| 2023-12-06 | SLONIN JONATHAN | Officer | — | D | Common Stock | 0 | 0.00 | — | 45,885 | — | ↗ |
| 2023-10-06 | Young Alethia | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-10-06 | YANG MICHAEL J. | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-10-06 | Ceesay Abraham | Director | A-Award | A | Stock Option (Right to Buy) | 30,967 | 29.80 | 922.8K | 30,967 | — | ↗ |
| 2023-10-06 | BIGAL MARCELO | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-08-02 | WINSTON ROY | Officer | S-Sale | D | Common Stock | 509 | 34.88 | 17.8K | 52,440 | — | ↗ |
| 2023-07-05 | Riker Lauren Bullaro | Officer | S-Sale | D | Common Stock | 643 | 38.91 | 25.0K | 22,687 | — | ↗ |
| 2023-06-14 | Williams Kristen Marie | Officer | A-Award | A | Common Stock | 10,950 | 0.00 | — | 31,842 | — | ↗ |
| 2023-06-14 | WINSTON ROY | Officer | A-Award | A | Common Stock | 10,950 | 0.00 | — | 52,306 | — | ↗ |
| 2023-06-14 | STACK DAVID M | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 245,400 | 38.74 | 9.51M | 245,400 | — | ↗ |
| 2023-06-14 | Riker Lauren Bullaro | Officer | S-Sale | D | Common Stock | 7 | 39.01 | 273.07 | 22,687 | — | ↗ |
| 2023-06-14 | Reinhart Charles A. III | Officer | A-Award | A | Stock Option (Right to Buy) | 22,500 | 38.74 | 871.7K | 22,500 | — | ↗ |
| 2023-06-14 | PACE GARY W | Director | A-Award | A | Stock Option (Right to Buy) | 12,925 | 38.74 | 500.7K | 12,925 | — | ↗ |
| 2023-06-14 | Kronenfeld Mark A. | Director | A-Award | A | Common Stock | 1,775 | 0.00 | — | 19,672 | — | ↗ |
| 2023-06-14 | HASTINGS PAUL J | Director | A-Award | A | Stock Option (Right to Buy) | 12,925 | 38.74 | 500.7K | 12,925 | — | ↗ |
| 2023-06-14 | GAUGLER DARYL | Officer | A-Award | A | Common Stock | 10,000 | 0.00 | — | 31,539 | — | ↗ |
| 2023-06-14 | Froimson Mark | Director | A-Award | A | Common Stock | 1,775 | 0.00 | — | 7,843 | — | ↗ |
| 2023-06-14 | CHRISTIE CHRISTOPHER | Director | A-Award | A | Stock Option (Right to Buy) | 12,925 | 38.74 | 500.7K | 12,925 | — | ↗ |
| 2023-06-14 | Brege Laura | Director | A-Award | A | Stock Option (Right to Buy) | 12,925 | 38.74 | 500.7K | 12,925 | — | ↗ |
| 2023-06-08 | Kronenfeld Mark A. | Director | M-Exempt | D | Stock Option (Right to Buy) | 15,000 | 29.90 | 448.5K | 0 | — | ↗ |
| 2023-06-07 | Williams Kristen Marie | Officer | S-Sale | D | Common Stock | 1,357 | 37.87 | 51.4K | 20,892 | — | ↗ |
| 2023-06-07 | WINSTON ROY | Officer | S-Sale | D | Common Stock | 1,857 | 37.87 | 70.3K | 41,356 | — | ↗ |
| 2023-06-07 | STACK DAVID M | Director / Officer | S-Sale | D | Common Stock | 5,326 | 37.87 | 201.7K | 153,781 | — | ↗ |
| 2023-06-07 | SLONIN JONATHAN | Officer | S-Sale | D | Common Stock | 490 | 37.87 | 18.6K | 36,323 | — | ↗ |
| 2023-06-07 | Riker Lauren Bullaro | Officer | S-Sale | D | Common Stock | 616 | 37.87 | 23.3K | 19,053 | — | ↗ |
| 2023-06-07 | Reinhart Charles A. III | Officer | S-Sale | D | Common Stock | 1,371 | 37.87 | 51.9K | 33,626 | — | ↗ |
| 2023-06-07 | REINHARDT MAX | Officer | S-Sale | D | Common Stock | 1,099 | 37.87 | 41.6K | 29,225 | — | ↗ |
| 2023-06-07 | McLoughlin Dennis | Officer | S-Sale | D | Common Stock | 1,057 | 37.87 | 40.0K | 38,115 | — | ↗ |
| 2023-06-07 | GAUGLER DARYL | Officer | S-Sale | D | Common Stock | 1,047 | 37.87 | 39.6K | 21,539 | — | ↗ |
| 2023-06-07 | Ellis Ronald J. Jr. | Officer | S-Sale | D | Common Stock | 1,162 | 37.87 | 44.0K | 30,909 | — | ↗ |
| 2023-06-06 | Williams Kristen Marie | Officer | S-Sale | D | Common Stock | 1,301 | 38.99 | 50.7K | 22,249 | — | ↗ |
| 2023-06-06 | WINSTON ROY | Officer | S-Sale | D | Common Stock | 1,779 | 38.99 | 69.4K | 43,213 | — | ↗ |
| 2023-06-06 | STACK DAVID M | Director / Officer | S-Sale | D | Common Stock | 5,058 | 38.99 | 197.2K | 159,107 | — | ↗ |
| 2023-06-06 | SLONIN JONATHAN | Officer | S-Sale | D | Common Stock | 471 | 38.99 | 18.4K | 36,813 | — | ↗ |
| 2023-06-06 | Riker Lauren Bullaro | Officer | S-Sale | D | Common Stock | 591 | 38.99 | 23.0K | 19,669 | — | ↗ |
| 2023-06-06 | Reinhart Charles A. III | Officer | S-Sale | D | Common Stock | 1,236 | 38.99 | 48.2K | 34,997 | — | ↗ |
| 2023-06-06 | REINHARDT MAX | Officer | S-Sale | D | Common Stock | 1,054 | 38.99 | 41.1K | 30,324 | — | ↗ |
| 2023-06-06 | McLoughlin Dennis | Officer | S-Sale | D | Common Stock | 1,014 | 38.99 | 39.5K | 39,172 | — | ↗ |
| 2023-06-06 | MOLLOY ANTHONY | Officer | S-Sale | D | Common Stock | 4,521 | 38.55 | 174.3K | 12,877 | — | ↗ |
| 2023-06-06 | GAUGLER DARYL | Officer | S-Sale | D | Common Stock | 1,005 | 38.99 | 39.2K | 22,586 | — | ↗ |
| 2023-06-06 | Ellis Ronald J. Jr. | Officer | S-Sale | D | Common Stock | 1,114 | 38.99 | 43.4K | 32,071 | — | ↗ |
| 2023-06-05 | MOLLOY ANTHONY | Officer | S-Sale | D | Common Stock | 2,267 | 38.28 | 86.8K | 17,398 | — | ↗ |
| 2023-06-05 | HASTINGS PAUL J | Director | S-Sale | D | Common Stock | 580 | 38.34 | 22.2K | 6,599 | — | ↗ |
| 2023-06-05 | GAUGLER DARYL | Officer | S-Sale | D | Common Stock | 1,000 | 38.74 | 38.7K | 23,591 | — | ↗ |
| 2023-06-05 | Brege Laura | Director | S-Sale | D | Common Stock | 600 | 38.74 | 23.2K | 9,547 | — | ↗ |
| 2023-05-31 | GAUGLER DARYL | Officer | M-Exempt | A | Common Stock | 2,500 | 34.00 | 85.0K | 26,894 | — | ↗ |
| 2023-05-15 | HASTINGS PAUL J | Director | S-Sale | D | Common Stock | 7,000 | 41.85 | 293.0K | 7,179 | — | ↗ |
| 2023-05-11 | PACE GARY W | Director | M-Exempt | A | Common Stock | 7,000 | 29.90 | 209.3K | 144,690 | — | ↗ |
| 2023-04-03 | Brege Laura | Director | M-Exempt | A | Common Stock | 7,000 | 29.90 | 209.3K | 17,147 | — | ↗ |
| 2023-03-14 | Ellis Ronald J. Jr. | Officer | — | D | Stock Option (Right to Buy) | 3,832 | 33.35 | 127.8K | 0 | — | ↗ |
| 2023-01-05 | MOLLOY ANTHONY | Officer | S-Sale | D | Common Stock | 546 | 38.31 | 20.9K | 19,450 | — | ↗ |
| 2023-01-04 | MOLLOY ANTHONY | Officer | S-Sale | D | Common Stock | 158 | 39.09 | 6.2K | 19,996 | — | ↗ |
| 2022-10-07 | REINHARDT MAX | Officer | S-Sale | D | Common Stock | 1,380 | 58.00 | 80.0K | 31,378 | — | ↗ |
| 2022-08-03 | WINSTON ROY | Officer | S-Sale | D | Common Stock | 476 | 55.70 | 26.5K | 44,992 | — | ↗ |
| 2022-08-03 | SLONIN JONATHAN | Officer | S-Sale | D | Common Stock | 308 | 55.70 | 17.2K | 37,079 | — | ↗ |
| 2022-07-11 | HASTINGS PAUL J | Director | S-Sale | D | Common Stock | 533 | 56.95 | 30.4K | 7,179 | — | ↗ |
| 2022-07-05 | SLONIN JONATHAN | Officer | S-Sale | D | Common Stock | 924 | 57.19 | 52.8K | 37,387 | — | ↗ |
| 2022-06-14 | LARANJEIRA CHARLES ANTHONY | Officer | M-Exempt | D | Stock Option (Right to Buy) | 6,000 | 0.00 | — | 9,000 | — | ↗ |
| 2022-06-08 | Williams Kristen Marie | Officer | A-Award | A | Common Stock | 9,900 | 0.00 | — | 23,550 | — | ↗ |
| 2022-06-08 | WINSTON ROY | Officer | A-Award | A | Stock Option (Right to Buy) | 24,800 | 59.39 | 1.47M | 24,800 | — | ↗ |
| 2022-06-08 | STACK DAVID M | Director / Officer | S-Sale | D | Common Stock | 501 | 61.96 | 31.0K | 142,251 | — | ↗ |
| 2022-06-08 | Riker Lauren Bullaro | Officer | A-Award | A | Stock Option (Right to Buy) | 14,600 | 59.39 | 867.1K | 14,600 | — | ↗ |
| 2022-06-08 | Reinhart Charles A. III | Officer | A-Award | A | Stock Option (Right to Buy) | 19,900 | 59.39 | 1.18M | 19,900 | — | ↗ |
| 2022-06-08 | REINHARDT MAX | Officer | A-Award | A | Stock Option (Right to Buy) | 19,900 | 59.39 | 1.18M | 19,900 | — | ↗ |
| 2022-06-08 | PACE GARY W | Director | A-Award | A | Stock Option (Right to Buy) | 8,225 | 59.39 | 488.5K | 8,225 | — | ↗ |
| 2022-06-08 | McLoughlin Dennis | Officer | A-Award | A | Stock Option (Right to Buy) | 19,900 | 59.39 | 1.18M | 19,900 | — | ↗ |
| 2022-06-08 | Kronenfeld Mark A. | Director | A-Award | A | Common Stock | 1,160 | 0.00 | — | 17,897 | — | ↗ |
| 2022-06-08 | HASTINGS PAUL J | Director | A-Award | A | Stock Option (Right to Buy) | 8,225 | 0.00 | — | 8,225 | — | ↗ |
| 2022-06-08 | Greenstreet Yvonne | Director | A-Award | A | Stock Option (Right to Buy) | 8,225 | 59.39 | 488.5K | 8,225 | — | ↗ |
| 2022-06-08 | CHRISTIE CHRISTOPHER | Director | A-Award | A | Common Stock | 1,160 | 0.00 | — | 3,486 | — | ↗ |
| 2022-06-08 | Brege Laura | Director | A-Award | A | Stock Option (Right to Buy) | 8,225 | 59.39 | 488.5K | 8,225 | — | ↗ |
| 2022-06-06 | Williams Kristen Marie | Officer | A-Award | A | Stock Option (Right to Buy) | 24,800 | 0.00 | — | 24,800 | — | ↗ |
| 2022-06-06 | WINSTON ROY | Officer | S-Sale | D | Common Stock | 123 | 63.69 | 7.8K | 35,160 | — | ↗ |
| 2022-06-06 | STACK DAVID M | Officer | A-Award | A | Stock Option (Right to Buy) | 160,900 | 0.00 | — | 160,900 | — | ↗ |
| 2022-06-06 | SLONIN JONATHAN | Officer | A-Award | A | Common Stock | 9,900 | 0.00 | — | 38,097 | — | ↗ |
| 2022-06-06 | Riker Lauren Bullaro | Officer | A-Award | A | Common Stock | 5,850 | 0.00 | — | 19,852 | — | ↗ |
| 2022-06-06 | Reinhart Charles A. III | Officer | S-Sale | D | Common Stock | 2,516 | 61.37 | 154.4K | 28,283 | — | ↗ |
| 2022-06-06 | REINHARDT MAX | Officer | A-Award | A | Stock Option (Right to Buy) | 19,900 | 0.00 | — | 19,900 | — | ↗ |
| 2022-06-06 | McLoughlin Dennis | Officer | S-Sale | D | Common Stock | 2,140 | 61.37 | 131.3K | 31,820 | — | ↗ |
| 2022-06-06 | MOLLOY ANTHONY | Officer | S-Sale | D | Common Stock | 1,830 | 60.40 | 110.5K | 12,000 | — | ↗ |
| 2022-06-06 | LARANJEIRA CHARLES ANTHONY | Officer | S-Sale | D | Common Stock | 267 | 61.98 | 16.5K | 25,852 | — | ↗ |
| 2022-06-06 | GAUGLER DARYL | Officer | S-Sale | D | Common Stock | 1,106 | 61.37 | 67.9K | 11,494 | — | ↗ |
| 2022-06-06 | Froimson Mark | Director | A-Award | A | Stock Option (Right to Buy) | 8,225 | 0.00 | — | 8,225 | — | ↗ |
| 2022-05-23 | SLONIN JONATHAN | Officer | M-Exempt | D | Stock Option (Right to Buy) | 2,000 | 0.00 | — | 35,500 | — | ↗ |
| 2022-05-09 | Froimson Mark | Director | S-Sale | D | Common Stock | 1,000 | 59.37 | 59.4K | 4,908 | — | ↗ |
| 2022-05-04 | GAUGLER DARYL | Officer | — | D | Stock Option (Right to Buy) | 10,000 | 47.65 | 476.5K | 0 | — | ↗ |
| 2022-04-28 | STACK DAVID M | Director / Officer | M-Exempt | A | Common Stock | 22,500 | 10.81 | 243.2K | 168,044 | — | ↗ |
| 2022-04-21 | REINHARDT MAX | Officer | M-Exempt | D | Stock Option (Right to Buy) | 12,500 | 42.54 | 531.8K | 100,000 | — | ↗ |
| 2022-04-20 | REINHARDT MAX | Officer | M-Exempt | D | Stock Option (Right to Buy) | 12,500 | 42.54 | 531.8K | 112,500 | — | ↗ |
| 2022-04-19 | REINHARDT MAX | Officer | M-Exempt | D | Stock Option (Right to Buy) | 12,500 | 42.54 | 531.8K | 125,000 | — | ↗ |
| 2022-04-18 | REINHARDT MAX | Officer | M-Exempt | D | Stock Option (Right to Buy) | 12,500 | 0.00 | — | 112,500 | — | ↗ |
| 2022-04-06 | MOLLOY ANTHONY | Officer | S-Sale | D | Common Stock | 16,060 | 76.03 | 1.22M | 23,990 | — | ↗ |
Executive team
Top executives
EBIT / Employee
39.9K
Shares Outstanding
39.34M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | Frank Lee Chief Executive Officer | 896.5K | 688.5K | 3.18M | 9.61M | 648.2K | 919.1K | 15.94M | 80.23% | ↗ |
| 2 | 2024 | Kristen Williams Chief Administrative Officer and Secretary | 519.3K | 246.8K | 2.61M | — | 220.8K | 15.6K | 3.61M | 72.23% | ↗ |
| 3 | 2024 | Daryl Gaugler Executive Vice President, Commercial Operations | 511.8K | 236.8K | 2.61M | — | 217.5K | 20.8K | 3.59M | 72.54% | ↗ |
| 4 | 2024 | Jonathan Slonin Chief Medical Officer | 535.0K | 247.4K | 1.72M | 131.0K | 227.3K | 20.8K | 2.88M | 64.20% | ↗ |
| 5 | 2024 | Shawn Cross Chief Financial Officer | 101.0K | 48.6K | 1.24M | 1.35M | — | 3.7K | 2.74M | 94.41% | ↗ |
| 6 | 2024 | Lauren Riker Former Interim Chief Financial Officer | 374.6K | 271.7K | 612.6K | — | 159.2K | 20.8K | 1.44M | 42.57% | ↗ |
| 7 | 2024 | Charles A. Reinhart, III Former Chief Financial Officer | 374.2K | 172.3K | 350.5K | — | — | 387.6K | 1.28M | 27.28% | ↗ |
| 8 | 2024 | David Stack Former Chief Executive Officer | 634.0K | 2.2K | — | — | — | 91.2K | 727.4K | 0.00% | ↗ |
| 9 | 2023 | David Stack Former Chief Executive Officer | 941.4K | 720.6K | 1.27M | 3.91M | — | 39.5K | 6.88M | 75.26% | ↗ |
| 10 | 2023 | David Stack Chief Executive Officer | 941.4K | 720.6K | 1.27M | 3.91M | — | 39.5K | 6.88M | 75.26% | ↗ |
| 11 | 2023 | Kristen Williams Chief Administrative Officer and Secretary | 501.0K | 225.9K | 424.2K | 438.1K | — | 11.6K | 1.60M | 53.87% | ↗ |
| 12 | 2023 | Jonathan Slonin Chief Medical Officer Officer | 490.2K | 220.3K | 424.2K | 438.1K | — | 20.3K | 1.59M | 54.13% | ↗ |
| 13 | 2023 | Jonathan Slonin Chief Medical Officer | 490.2K | 220.3K | 424.2K | 438.1K | — | 20.3K | 1.59M | 54.13% | ↗ |
| 14 | 2023 | Daryl Gaugler Executive Vice President, Commercial Operations | 501.7K | 225.9K | 387.4K | 398.3K | — | 20.3K | 1.53M | 51.23% | ↗ |
| 15 | 2023 | Daryl Gaugler Chief Operating Officer | 501.7K | 225.9K | 387.4K | 398.3K | — | 20.3K | 1.53M | 51.23% | ↗ |
| 16 | 2023 | Charles A. Reinhart, III Chief Financial Officer | 486.7K | 219.1K | 348.7K | 358.5K | — | 14.5K | 1.43M | 49.54% | ↗ |
| 17 | 2023 | Charles A. Reinhart, III Former Chief Financial Officer | 486.7K | 219.1K | 348.7K | 358.5K | — | 14.5K | 1.43M | 49.54% | ↗ |
| 18 | 2022 | David Stack Former Chief Executive Officer | 910.1K | 618.9K | 1.28M | 4.03M | — | 14.9K | 6.85M | 77.47% | ↗ |
| 19 | 2022 | David Stack Chief Executive Officer | 910.1K | 618.9K | 1.28M | 4.03M | — | 14.9K | 6.85M | 77.47% | ↗ |
| 20 | 2022 | Daryl Gaugler Chief Operating Officer | 469.9K | 287.9K | 766.1K | 746.5K | — | 20.9K | 2.29M | 66.01% | ↗ |
| 21 | 2022 | Daryl Gaugler Executive Vice President, Commercial Operations | 469.9K | 287.9K | 766.1K | 746.5K | — | 20.9K | 2.29M | 66.01% | ↗ |
| 22 | 2022 | Anthony Molloy Chief Legal and Compliance Officer | 400.0K | 160.0K | 708.3K | 764.1K | — | 21.4K | 2.05M | 71.69% | ↗ |
| 23 | 2022 | Kristen Williams Chief Administrative Officer and Secretary | 457.0K | 330.4K | 588.0K | 621.2K | — | 12.2K | 2.01M | 60.19% | ↗ |
| 24 | 2022 | Jonathan Slonin Chief Medical Officer | 463.5K | 185.4K | 588.0K | 621.2K | — | 20.9K | 1.88M | 64.35% | ↗ |
| 25 | 2022 | Jonathan Slonin Chief Medical Officer Officer | 463.5K | 185.4K | 588.0K | 621.2K | — | 20.9K | 1.88M | 64.35% | ↗ |
| 26 | 2022 | Charles A. Reinhart, III Chief Financial Officer | 475.0K | 290.0K | 472.2K | 498.5K | — | 15.6K | 1.75M | 55.43% | ↗ |
| 27 | 2022 | Charles A. Reinhart, III Former Chief Financial Officer | 475.0K | 290.0K | 472.2K | 498.5K | — | 15.6K | 1.75M | 55.43% | ↗ |
| 28 | 2021 | David Stack Chief Executive Officer | 883.6K | 751.1K | 1.09M | 3.70M | 506.8K | 14.7K | 6.94M | 68.94% | ↗ |
| 29 | 2021 | Roy Winston Chief Medical Officer | 515.0K | 275.0K | 721.5K | 760.9K | 184.6K | 22.3K | 2.48M | 59.79% | ↗ |
| 30 | 2021 | Jonathan Slonin Chief Clinical Officer | 426.2K | 212.9K | 667.6K | 639.5K | 145.6K | 30.6K | 2.12M | 61.59% | ↗ |
| 31 | 2021 | Jonathan Slonin Chief Medical Officer Officer | 426.2K | 212.9K | 639.5K | 667.6K | 145.6K | 20.6K | 2.11M | 61.88% | ↗ |
| 32 | 2021 | Max Reinhardt President, Rest of World | 551.1K | 275.0K | 426.7K | 485.5K | 197.6K | 30.9K | 1.97M | 46.38% | ↗ |
| 33 | 2021 | Kristen Williams Chief Administrative Officer and Secretary | 515.0K | 275.0K | 426.7K | 485.5K | 184.6K | 11.5K | 1.90M | 48.05% | ↗ |
| 34 | 2021 | Charles A. Reinhart, III Chief Financial Officer | 460.4K | 230.2K | 365.8K | 416.2K | 165.0K | 25.2K | 1.66M | 47.03% | ↗ |
| 35 | 2020 | David Stack Chief Executive Officer | 889.9K | 686.3K | 1.59M | 6.17M | — | 14.7K | 9.34M | 82.97% | ↗ |
| 36 | 2020 | Donald Manning Chief Medical Officer | 304.6K | 150.4K | 1.27M | 1.46M | — | 55.3K | 3.24M | 84.25% | ↗ |
| 37 | 2020 | Max Reinhardt President, Rest of World | 555.0K | 268.2K | 667.1K | 784.8K | — | 27.0K | 2.30M | 63.07% | ↗ |
| 38 | 2020 | Kristen Williams Chief Administrative Officer and Secretary | 518.5K | 250.0K | 667.1K | 784.8K | — | 19.8K | 2.24M | 64.81% | ↗ |
| 39 | 2020 | Roy Winston Chief Medical Officer | 515.8K | 250.0K | 667.1K | 784.9K | — | 12.3K | 2.23M | 65.11% | ↗ |
| 40 | 2020 | Charles A. Reinhart, III Chief Financial Officer | 463.7K | 223.5K | 600.4K | 706.4K | — | 15.2K | 2.01M | 65.04% | ↗ |
| 41 | 2019 | David Stack Chief Executive Officer | 832.0K | 624.7K | 1.09M | 3.24M | — | 17.2K | 5.81M | 74.62% | ↗ |
| 42 | 2019 | Max Reinhardt President, Rest of World | 266.0K | 140.0K | — | 4.15M | — | 23.3K | 4.58M | 90.62% | ↗ |
| 43 | 2019 | Max Reinhardt President | 266.0K | 140.0K | — | 4.15M | — | 23.3K | 4.58M | 90.62% | ↗ |
| 44 | 2019 | Kristen Williams Chief Administrative Officer and Secretary | 479.2K | 225.0K | 243.8K | 720.9K | — | 23.7K | 1.69M | 56.99% | ↗ |
| 45 | 2019 | Roy Winston Chief Clinical Officer | 408.7K | 225.0K | 243.8K | 720.9K | — | 13.4K | 1.61M | 59.86% | ↗ |
| 46 | 2019 | Roy Winston Chief Medical Officer | 408.7K | 225.0K | 243.8K | 720.9K | — | 13.4K | 1.61M | 59.86% | ↗ |
| 47 | 2019 | Charles A. Reinhart, III Chief Financial Officer | 433.5K | 195.0K | 191.6K | 561.0K | — | 8.7K | 1.39M | 54.15% | ↗ |
| 48 | 2018 | David Stack Chief Executive Officer | 807.7K | 679.2K | 1.09M | 3.24M | — | 16.4K | 5.84M | 74.24% | ↗ |
| 49 | 2018 | Dennis McLoughlin Chief Commercial Officer | 319.2K | 200.0K | 302.0K | 1.69M | — | 16.6K | 2.53M | 78.80% | ↗ |
| 50 | 2018 | Richard Scranton Chief Medical Officer | 457.7K | 250.0K | 302.0K | 1.23M | — | 26.0K | 2.27M | 67.63% | ↗ |
| 51 | 2018 | Kristen Williams Chief Administrative Officer and Secretary | 459.0K | 250.0K | 302.0K | 900.4K | — | 23.7K | 1.94M | 62.14% | ↗ |
| 52 | 2018 | Charles A. Reinhart, III Chief Financial Officer | 420.8K | 220.0K | 191.8K | 571.7K | — | 3.4K | 1.41M | 54.24% | ↗ |
| 53 | 2017 | David Stack Chief Executive Officer | 784.2K | 467.1K | 1.79M | 1.67M | — | 10.7K | 4.72M | 73.26% | ↗ |
| 54 | 2017 | Scott Braunstein Former Chief Operating Officer | 440.5K | 158.0K | 486.2K | 657.9K | — | 966.00 | 1.74M | 65.62% | ↗ |
| 55 | 2017 | Richard Scranton Chief Medical Officer | 378.5K | 150.0K | 386.8K | 770.4K | — | 966.00 | 1.69M | 68.61% | ↗ |
| 56 | 2017 | Richard Scranton Chief Scientific Officer | 378.5K | 150.0K | 386.8K | 770.4K | — | 966.00 | 1.69M | 68.61% | ↗ |
| 57 | 2017 | Kristen Williams Chief Administrative Officer and Secretary | 432.5K | 155.9K | 486.2K | 452.7K | — | 420.00 | 1.53M | 61.46% | ↗ |
| 58 | 2017 | Charles A. Reinhart, III Chief Financial Officer | 408.7K | 147.2K | 386.8K | 360.1K | — | 16.2K | 1.32M | 56.63% | ↗ |
| 59 | 2016 | David Stack Chief Executive Officer | 761.3K | 396.3K | 1.34M | 2.32M | — | 8.2K | 4.82M | 75.80% | ↗ |
| 60 | 2016 | Charles A. Reinhart, III Chief Financial Officer | 269.2K | 85.5K | — | 2.02M | — | 32.1K | 2.41M | 83.96% | ↗ |
| 61 | 2016 | James Scibetta President and Former Chief Financial Officer | 494.2K | 198.0K | 655.5K | 980.6K | — | 966.00 | 2.33M | 70.24% | ↗ |
| 62 | 2016 | Robert Weiland Chief Commercial Officer | 270.4K | 86.0K | — | 1.47M | — | 98.1K | 1.92M | 76.39% | ↗ |
| 63 | 2016 | Scott Braunstein Senior Vice President, Strategy and Corporate Development | 419.0K | 134.4K | 353.0K | 680.5K | — | 966.00 | 1.59M | 65.08% | ↗ |
| 64 | 2016 | Scott Braunstein Former Chief Operating Officer | 419.0K | 134.4K | 353.0K | 680.5K | — | 966.00 | 1.59M | 65.08% | ↗ |
| 65 | 2016 | Kristen Williams Chief Administrative Officer, General Counsel and Secretary | 417.3K | 134.4K | 353.0K | 680.5K | — | 420.00 | 1.59M | 65.18% | ↗ |
| 66 | 2016 | Kristen Williams Chief Administrative Officer and Secretary | 417.3K | 134.4K | 353.0K | 680.5K | — | 420.00 | 1.59M | 65.18% | ↗ |
| 67 | 2015 | Scott Braunstein Former Chief Operating Officer | 182.3K | 75.0K | — | 2.50M | — | 630.00 | 2.76M | 90.66% | ↗ |
| 68 | 2015 | Scott Braunstein Senior Vice President, Strategy and Corporate Development | 182.3K | 75.0K | — | 2.50M | — | 630.00 | 2.76M | 90.66% | ↗ |
| 69 | 2015 | James Scibetta President and Chief Financial Officer | 409.1K | 237.5K | — | 1.09M | — | 966.00 | 1.74M | 62.77% | ↗ |
| 70 | 2015 | James Scibetta President and Former Chief Financial Officer | 409.1K | 237.5K | — | 1.09M | — | 966.00 | 1.74M | 62.77% | ↗ |
| 71 | 2015 | Kristen Williams Chief Administrative Officer, General Counsel and Secretary | 349.1K | 200.0K | 595.7K | 592.1K | — | 630.00 | 1.74M | 68.36% | ↗ |
| 72 | 2015 | Kristen Williams Chief Administrative Officer and Secretary | 349.1K | 200.0K | 595.7K | 592.1K | — | 630.00 | 1.74M | 68.36% | ↗ |
| 73 | 2015 | James B. Jones Senior Vice President and Chief Medical Officer | 154.3K | 120.0K | — | 1.23M | — | 420.00 | 1.50M | 81.68% | ↗ |
| 74 | 2015 | David Stack Chief Executive Officer | 734.5K | 481.0K | — | — | — | 2.8K | 1.22M | 0.00% | ↗ |
| 75 | 2014 | David Stack President and Chief Executive Officer | 596.5K | 425.0K | — | 6.39M | — | 2.8K | 7.41M | 86.18% | ↗ |
| 76 | 2014 | David Stack Chief Executive Officer | 593.2K | 425.0K | — | 6.39M | — | 2.8K | 7.41M | 86.22% | ↗ |
| 77 | 2014 | James Scibetta Senior Vice President and Chief Financial Officer | 369.3K | 165.0K | — | 2.98M | — | 966.00 | 3.52M | 84.77% | ↗ |
| 78 | 2014 | James Scibetta President and Former Chief Financial Officer | 367.7K | 165.0K | — | 2.98M | — | 966.00 | 3.51M | 84.81% | ↗ |
| 79 | 2014 | James Scibetta President and Chief Financial Officer | 367.7K | 165.0K | — | 2.98M | — | 966.00 | 3.51M | 84.81% | ↗ |
| 80 | 2014 | Taunia Markvicka Senior Vice President and Chief Commercial Officer | 353.2K | 150.0K | — | 2.98M | — | 630.00 | 3.48M | 85.54% | ↗ |
| 81 | 2014 | Kristen Williams Chief Administrative Officer and Secretary | 326.7K | 120.0K | — | 1.70M | — | 420.00 | 2.15M | 79.20% | ↗ |
| 82 | 2014 | Kristen Williams Chief Administrative Officer, General Counsel and Secretary | 294.3K | 120.0K | — | 1.70M | — | 420.00 | 2.12M | 80.41% | ↗ |
| 83 | 2014 | Gary Patou Chief Medical Officer | 317.6K | 90.0K | — | 1.48M | — | — | 1.89M | 78.38% | ↗ |
| 84 | 2013 | David Stack Chief Executive Officer | 509.0K | 407.2K | — | — | — | 2.8K | 919.0K | 0.00% | ↗ |
| 85 | 2013 | David Stack President and Chief Executive Officer | 509.0K | 407.2K | — | — | — | 2.8K | 919.0K | 0.00% | ↗ |
| 86 | 2013 | James Scibetta President and Chief Financial Officer | 328.4K | 140.0K | — | — | — | 630.00 | 469.0K | 0.00% | ↗ |
| 87 | 2013 | James Scibetta Senior Vice President and Chief Financial Officer | 328.4K | 140.0K | — | — | — | 630.00 | 469.0K | 0.00% | ↗ |
| 88 | 2013 | Taunia Markvicka Senior Vice President and Chief Commercial Officer | 318.9K | 140.0K | — | — | — | 630.00 | 459.5K | 0.00% | ↗ |
| 89 | 2013 | Lauren Riker Former Interim Chief Financial Officer | 218.4K | 70.0K | — | — | — | 378.00 | 288.8K | 0.00% | ↗ |
| 90 | 2013 | Gary Patou Chief Medical Officer | 229.4K | 50.0K | — | — | — | — | 279.4K | 0.00% | ↗ |
| 91 | 2012 | David Stack Chief Executive Officer | 462.0K | 231.0K | — | 2.48M | — | 2.9K | 3.17M | 78.08% | ↗ |
| 92 | 2012 | David Stack President and Chief Executive Officer | 462.0K | 231.0K | — | 2.48M | — | 2.9K | 3.17M | 78.08% | ↗ |
| 93 | 2012 | Gary Patou Chief Medical Officer | 285.9K | 50.0K | — | 1.42M | — | — | 1.76M | 80.88% | ↗ |
| 94 | 2012 | James Scibetta Chief Financial Officer | 318.1K | 100.0K | — | 1.06M | — | 654.00 | 1.48M | 71.72% | ↗ |
| 95 | 2012 | James Scibetta Senior Vice President and Chief Financial Officer | 318.1K | 100.0K | — | 1.06M | — | 654.00 | 1.48M | 71.72% | ↗ |
| 96 | 2012 | Taunia Markvicka Senior Vice President and Chief Commercial Officer | 315.0K | 65.0K | — | 1.06M | — | 436.00 | 1.44M | 73.63% | ↗ |
| 97 | 2012 | Taunia Markvicka Senior Vice President and Chief Commercial Officer | 315.0K | 65.0K | — | 1.06M | — | 436.00 | 1.44M | 73.63% | ↗ |
| 98 | 2011 | David Stack President and Chief Executive Officer | 409.0K | 206.0K | — | — | — | 2.8K | 617.8K | 0.00% | ↗ |
| 99 | 2011 | David Stack Chief Executive Officer | 409.0K | 206.0K | — | — | — | 1.5K | 616.6K | 0.00% | ↗ |
| 100 | 2011 | Gary Patou Chief Medical Officer | 317.6K | 100.0K | — | — | — | 19.1K | 436.7K | 0.00% | ↗ |
| 101 | 2011 | James Scibetta Chief Financial Officer | 276.1K | 100.0K | — | — | — | 1.5K | 377.6K | 0.00% | ↗ |
| 102 | 2011 | James Scibetta Senior Vice President and Chief Financial Officer | 276.1K | 100.0K | — | — | — | 630.00 | 376.7K | 0.00% | ↗ |
| 103 | 2011 | Taunia Markvicka Senior Vice President and Chief Commercial Officer | 220.0K | 100.0K | — | — | — | 420.00 | 320.4K | 0.00% | ↗ |
| 104 | 2010 | David Stack Chief Executive Officer | 400.0K | — | — | 1.11M | — | 1.5K | 1.51M | 73.48% | ↗ |
| 105 | 2010 | Gary Patou Chief Medical Officer | 336.7K | 300.0K | — | 295.0K | — | 19.1K | 950.7K | 31.03% | ↗ |
| 106 | 2010 | James Scibetta Chief Financial Officer | 270.0K | — | — | 370.7K | — | 1.5K | 642.2K | 57.73% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Frank D. Lee | Chief Executive Officer & Director | 2M | male |
| Lauren Bullaro Riker | Principal Accounting Officer & Senior Vice President of Finance | 2M | female |
| Brendan Teehan | Chief Commercial Officer | 1M | male |
| Jonathan Slonin | Chief Medical Officer | 1M | — |
| Kristen Williams | Chief Administrative Officer & Secretary | 1M | female |
| Shawn Cross | Chief Financial Officer | 1M | male |
| Anthony Molloy | Chief Legal & Compliance Officer | 581.4K | male |
| Krys Corbett | Chief Business Officer | — | female |
| Christopher C. Young | Chief Manufacturing Officer | — | male |
| Susan Mesco | Head of Investor Relations | — | female |
ESG Rating
ESG Score History DRUG MANUFACTURERS - SPECIALTY & GENERIC
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for PCRX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
